أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

adjutor healthcare pty ltd - vadadustat, quantity: 150 mg - tablet, film coated - excipient ingredients: magnesium stearate; sodium starch glycollate type a; hypromellose; silicon dioxide; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - vafseo is indicated for the treatment of anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

adjutor healthcare pty ltd - vadadustat, quantity: 300 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; microcrystalline cellulose; hypromellose; silicon dioxide; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - vafseo is indicated for the treatment of anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

adjutor healthcare pty ltd - vadadustat, quantity: 450 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate type a; hypromellose; magnesium stearate; silicon dioxide; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - vafseo is indicated for the treatment of anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - antianemic preparations - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

الاتحاد الأوروبي - الإنجليزية - EMA (European Medicines Agency)

astellas pharma europe b.v. - roxadustat - anemia; kidney failure, chronic - antianemic preparations - evrenzo is indicated for treatment of adult patients with symptomatic anaemia associated with chronic kidney disease (ckd).

ماليزيا - الإنجليزية - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

imeks pharma sdn. bhd. - desloratadine -

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

hi-tech pharmacal co., inc. - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride anhydrous 20 mg in 1 ml - lidocaine hydrochloride jelly usp, 2% (anestacon® ) is indicated for prevention and control of pain in procedures involving the male and female urethra, for topical treatment of painful urethritis, and as an anesthetic lubricant for endotracheal intubation (oral and nasal). lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type or to other components of lidocaine hydrochloride jelly usp, 2% (anestacon® ).

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

novem healthcare pte ltd - desloratadine - tablet, film coated - desloratadine 5 mg

اليابان - الإنجليزية - すりの適正使用協議会 RAD-AR Council, Japan

mitsubishi tanabe pharma corporation - vadadustat - white tablet, diameter: about 8.1 mm, thickness: about 4.4 mm

اليابان - الإنجليزية - すりの適正使用協議会 RAD-AR Council, Japan

mitsubishi tanabe pharma corporation - vadadustat - yellow oval tablet, major axis: approximately 12.9 mm, minor axis: approximately 7.8 mm, thickness: approximately 6.0 mm